Newsroom

Sorted by: Latest

-

Mckesson Corporation Announces Third Quarter Fiscal 2026 Earnings Release Date

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2026 financial results after market close on Wednesday, February 4, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson’s Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services l...
-

Fastenal Announces CEO Transition

WINONA, Minn.--(BUSINESS WIRE)--Fastenal Company (Nasdaq: FAST) (the 'Company' or 'Fastenal') announced today that Daniel L. Florness communicated to the Board of Directors on December 19, 2025 his decision to step out of his role as Chief Executive Officer (CEO) of Fastenal on July 16, 2026. On December 19, 2025, Fastenal's Board appointed Jeffery M. Watts, Fastenal's current President and Chief Sales Officer, to succeed Mr. Florness as Fastenal's CEO effective as of July 16, 2026. "The Board...
-

Cintas Proposes to Acquire UniFirst for $275.00 Per Share in Cash

CINCINNATI--(BUSINESS WIRE)--Cintas Corporation (Nasdaq: CTAS) today announced that it submitted a proposal to the Board of Directors of UniFirst Corporation (NYSE: UNF) to acquire all outstanding common and class B shares of UniFirst for $275.00 per share (the “Proposal”) in cash. The Proposal, which was delivered to the UniFirst Board on December 12, 2025, implies a total value for UniFirst of approximately $5.2 billion and offers UniFirst shareholders a 64% premium to UniFirst’s ninety-day a...
-

Pitney Bowes Inc. Announces Results and Upsize of Its Cash Tender Offers for Two Series of Notes

STAMFORD, Conn.--(BUSINESS WIRE)--Pitney Bowes Inc. (NYSE:PBI) (“Pitney Bowes” or the “Company”) announced today the expiration of and results for its previously announced offers to purchase for cash (each offer a “Tender Offer” and collectively, the “Tender Offers”), subject to certain terms and conditions, up to $80,000,000 aggregate principal amount (subject to increase or decrease by the Company, the “Maximum Tender Amount”) of its outstanding 6.70% Notes due 2043 (the “2043 Notes”) and 5.2...
-

Sharon AI Completes US$100m Convertible Note Capital Raising

NEW YORK--(BUSINESS WIRE)--SharonAI Holdings Inc. and its subsidiaries (“Sharon AI”), Australia’s leading Neocloud (SHAZ:OTC Markets, SHAZW:OTC Markets), announces the completion of an at least US$100m capital raising in the form of a Convertible Note, as of the close of business on Friday, the 19th of December, 2025. Both new and existing institutional investors and strategic corporates participated, with Canaccord Genuity Australia appointed as the sole lead manager. The net proceeds from the...
-

Media Partners Asia Launches the AETHER Summit Uniting AI, Creativity, and Infrastructure

SINGAPORE--(BUSINESS WIRE)--Media Partners Asia (MPA), the organiser of APOS, Asia’s leading media and technology summit, today announced the launch of AETHER, a new invitation-only global summit, convening Global & Local Leaders to be held at Marina Bay Sands, Singapore, on January 15–16, 2026. AETHER is conceived as the first curated forum in APAC to unite leaders across Artificial Intelligence, immersive and generative technologies, connectivity and compute infrastructure, creativity and...
-

InSilicoTrials With The Jackson Laboratory Lead CARDIOVERSE, a $30M Initiative Funded by ARPA-H to Redefine Cardiac Drug Safety with Virtual Heart Models

WILMINGTON, Del.--(BUSINESS WIRE)--Predicting how a person’s heart will respond to a new medicine remains one of the most persistent blind spots in drug development. Even with decades of scientific progress, cardiotoxicity can still emerge unexpectedly, carrying enormous financial costs and, more importantly, real human consequences. Today, that challenge is being met with a bold new vision. InSilicoTrials is proud to lead with The Jackson Laboratory (JAX) under the leadership of Dr. Matt Mahon...
-

Natera to Participate in the 44th Annual J.P. Morgan Healthcare Conference

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, Jan. 13, 2026 at 4:30 p.m. PT (7:30 p.m. ET). Members of management will deliver a presentation and host a Q&A with the investment community at the conference. A live webcast may be accessed through the investor relations section of the Natera websit...
-

BODi Launches “10 Minute BODi,” the Science-Backed Breakthrough of Microdose Fitness That Delivers Real Results in Just 10 Minutes a Day

EL SEGUNDO, Calif.--(BUSINESS WIRE)--BODi (NASDAQ: BODI) today announced the launch of “10 Minute BODi,” the breakthrough Microdose Fitness subscription that anyone can start, no matter how busy, out of shape, or intimidated they feel by traditional workouts. This curated collection of more than 400 10-minute workouts, anchored by four new Microdose Fitness programs, each built around a four-week training cycle, is designed to deliver real results for just $10 a month, with the first 10 days fr...
-

Shift4 Launches Global Stablecoin Settlement Platform, Unlocking Faster Payments for Merchants

CENTER VALLEY, Pa.--(BUSINESS WIRE)--Shift4 (NYSE: FOUR), a global leader in integrated payments and commerce technology, has announced the launch of its stablecoin settlement platform. Hundreds of thousands of merchants globally will now have the option to receive money more quickly and move funds 24/7 via stablecoin settlement, without the constraints of typical banking hours or other limitations. This solution will allow merchants to opt into being settled in popular stablecoins such as USDC...